STADA to acquire Biopharma’s prescription and consumer health business

This article was originally published here

As part of the deal, STADA will also acquire Biopharma’s two GMP-certified production facilities in the city of Bila Tserkva, Kiev. The shareholders of Biopharma will retain the

The post STADA to acquire Biopharma’s prescription and consumer health business appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply